266 related articles for article (PubMed ID: 35787253)
21. Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.
Laskari K; Mavragani CP; Tzioufas AG; Moutsopoulos HM
Arthritis Res Ther; 2010; 12(6):R208. PubMed ID: 21059275
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.
Pinto-Peñaranda LF; Duque-Caballero V; Márquez-Hernández JD; Muñoz-Grajales C; Velásquez-Franco CJ
Clin Rheumatol; 2015 May; 34(5):897-903. PubMed ID: 25592376
[TBL] [Abstract][Full Text] [Related]
23. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Smith E; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley D; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan A; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
Lupus; 2019 Apr; 28(5):613-620. PubMed ID: 30871425
[TBL] [Abstract][Full Text] [Related]
24. Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy.
Timlin H; Magder L; Petri M
Cureus; 2017 Dec; 9(12):e1907. PubMed ID: 29410944
[TBL] [Abstract][Full Text] [Related]
25. [Therapy of lupus nephritis with mycophenolate mofetil].
Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
Med Pregl; 2007; 60 Suppl 2():124-7. PubMed ID: 18928177
[TBL] [Abstract][Full Text] [Related]
26. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
[TBL] [Abstract][Full Text] [Related]
27. Lupus nephritis in Indigenous Australians: a single-centre study.
Nigam A; Baer R; Green S; Neuen BL; Vile A; Mantha M
Intern Med J; 2020 Jul; 50(7):830-837. PubMed ID: 31760686
[TBL] [Abstract][Full Text] [Related]
28. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F
Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
[TBL] [Abstract][Full Text] [Related]
30. Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.
Nakano M; Kubo K; Shirota Y; Iwasaki Y; Takahashi Y; Igari T; Inaba Y; Takeshima Y; Tateishi S; Yamashita H; Miyazaki M; Sato H; Kanda H; Kaneko H; Ishii T; Fujio K; Tanaka N; Mimori A
Lupus; 2019 Aug; 28(9):1062-1073. PubMed ID: 31296139
[TBL] [Abstract][Full Text] [Related]
31. [Therapy of lupus nephritis with mycophenolate mofetil].
Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
Med Pregl; 2008; 61(5-6):270-3. PubMed ID: 19102074
[TBL] [Abstract][Full Text] [Related]
32. Proliferative lupus nephritis in the absence of overt systemic lupus erythematosus: A historical study of 12 adult patients.
Touzot M; Terrier CS; Faguer S; Masson I; François H; Couzi L; Hummel A; Quellard N; Touchard G; Jourde-Chiche N; Goujon JM; Daugas E;
Medicine (Baltimore); 2017 Dec; 96(48):e9017. PubMed ID: 29310419
[TBL] [Abstract][Full Text] [Related]
33. Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.
Sigdel MR; Kafle MP; Shah DS
BMC Nephrol; 2016 Oct; 17(1):145. PubMed ID: 27717323
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
35. Induction therapy for membranous lupus nephritis: a systematic review and network meta-analysis.
Tang KT; Tseng CH; Hsieh TY; Chen DY
Int J Rheum Dis; 2018 Jun; 21(6):1163-1172. PubMed ID: 29879319
[TBL] [Abstract][Full Text] [Related]
36. Long-term renal survival of paediatric patients with lupus nephritis.
Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
[TBL] [Abstract][Full Text] [Related]
38. Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study.
Lim CC; Tan HZ; Hao Y; Chin YM; Woo KT; Chan CM; Choo JCJ
Intern Med J; 2018 Sep; 48(9):1117-1123. PubMed ID: 29740923
[TBL] [Abstract][Full Text] [Related]
39. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
[TBL] [Abstract][Full Text] [Related]
40. Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
Walsh M; James M; Jayne D; Tonelli M; Manns BJ; Hemmelgarn BR
Clin J Am Soc Nephrol; 2007 Sep; 2(5):968-75. PubMed ID: 17702723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
